<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32651855</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Meta-analysis of the association between CHCHD10 Pro34Ser variant and the risk of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>631</EndPage><MedlinePgn>625-631</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04579-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS), one of the motor neuron diseases, appears to be caused by genetic and environmental risk factors. However, the influence of Pro34Ser variant of CHCHD10 gene in increasing risk of ALS remains indeterminate. This study conducted a meta-analysis to establish the association between Pro34Ser variant of CHCHD10 gene and risk of ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PubMed, Web of Science, and Embase databases were systematically searched for genome-wide association studies or case-control studies published up to March 28, 2020, on the association between Pro34Ser variant and risk of ALS. Data from eligible studies were extracted and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twelve case-control studies involving 7442 patients with sporadic ALS and 75,371 controls were analyzed. The Pro34Ser variant was not associated with increased risk of ALS disease based on fixed-effects meta-analysis (Pro34Ser-positive vs Pro34Ser-negative: OR 1.23, 95% CI 0.90 to 1.69, P&#x2009;=&#x2009;0.201).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Existing evidence suggests that Pro34Ser variant in CHCHD10 is not associated with risk of ALS, particularly in Caucasian participants. However, our results ought to be validated using large, well-designed studies, especially in Asian and African populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Baiyuan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Chenghui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine, Sichuan Academy of Medical Science &amp; Sichuan Provincial People's Hospital, 32# West. Section 2, 1st RingRoad, Chengdu, 610072, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ren</LastName><ForeName>Junwei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Fuling Central Hospital of Chongqing City, No.2, Gaosuntang Road, Fuling District, Chongqing, 408000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Chengqing</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Keting</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Liusha</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Han</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Mingling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Chengdu Seventh People's Hospital, 1188 Shuangxing Avenue, Shuangliu District, Chengdu, 610213, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhenfang</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-4328-6438</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Affiliated Sichuan Provincial Rehabilitation Hospital of Chengdu University of TCM, 81, Ba Yi Road, Wenjiang, Chengdu, 611135, Sichuan Province, China. 1326581972@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20YYJC0146</GrantID><Agency>Sichuan application basic research project</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554426">CHCHD10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">CHCHD10</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Pro34Ser</Keyword><Keyword MajorTopicYN="N">Variant</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32651855</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04579-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04579-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D (2016) The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol 138:225&#x2013;238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-802973-2.00013-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93(11):1617&#x2013;1628</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Jiang H, Wang F, Li S, Wu C, Bao J, Zhu Y, Xu Z, Liu B, Ren H, Yang X (2019) UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis. Neurol Sci 40(11):2293&#x2013;2302</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03951-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94&#x2013;102</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Plutino M, Bannwarth S, Villa E, Cisneros-Barroso E, Roy M, Ortega-Vila B, Fragaki K, Lespinasse F, Pinero-Martos E, Aug&#xe9; G, Moore D, Burt&#xe9; F, Lacas-Gervais S, Kageyama Y, Itoh K, Yu-Wai-Man P, Sesaki H, Ricci JE, Vives-Bauza C, Paquis-Flucklinger V (2016) CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol Med 8(1):58&#x2013;72</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201505496</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K et al (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137(Pt 8):2329&#x2013;2345</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S et al (2014) Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol Aging 35(12):2884.e1&#x2013;2884.e4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Sabatelli M, Caponnetto C, Traynor BJ, Johnson JO et al (2015) CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 36(4):1767.e3&#x2013;1767.e6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.01.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelkarim S, Morgan S, Plagnol V, Lu CH, Adamson G, Howard R, Malaspina A, Orrell R, Sharma N, Sidle K, Clarke J, Fox NC, Rossor MN, Warren JD, Clark CN, Rohrer JD, Fisher EMC, Mead S, Pittman A, Fratta P (2016) CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia. Brain 139(Pt 2):e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv223</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Min EALSSC (2018) CHCHD10 variants in amyotrophic lateral sclerosis: where is the evidence? Ann Neurol 84(1):110&#x2013;116</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25273</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557&#x2013;560</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning P, Yang X, Yang B, Zhao Q, Huang H, An R, Chen Y, Hu F, Xu Z, Xu Y (2018) Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis. Neurol Sci 39(7):1261&#x2013;1266</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3411-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533&#x2013;1537</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7121.1533</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C, Shaw AD, Hallupp M, Bartley L, McCann H, Brooks WS, Loy CT, Schofield PR, Mather KA, Kochan NA, Sachdev PS, Halliday GM, Piguet O, Hodges JR, Kwok JBJ (2015) Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? Brain 138(Pt 10):e385</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K et al (2015) Reply: is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? Brain 138(Pt 10):e386</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv116</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttila S, Jokela M, Saukkonen AM, Toivanen J, Palmio J, Lahdesmaki J et al (2017) CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients. J Neurol Neurosurg Psychiatry 88(3):272&#x2013;277</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314154</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K et al (2014) Reply: are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis? Brain 137(Pt 12):e314</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K et al (2015) Reply: a distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation. Brain 138(Pt 9):e377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Xi Z, Zinman L, Bruni AC, Maletta RG, Curcio SA et al (2015) Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain 138(Pt 9):e380</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronchi D, Riboldi G, Del Bo R, Ticozzi N, Scarlato M, Galimberti D et al (2015) CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. Brain 138(Pt 8):e372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CH, Topp S, Gkazi AS, Troakes C, Miller JW, de Majo M et al (2015) The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Neurobiol Aging 36(10):2908.e17&#x2013;2908.e18</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Marroquin N, Stranz S, Muller K, Wieland T, Ruf WP, Brockmann SJ et al (2016) Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant. Brain 139(Pt 2):e8</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv218</ArticleId></ArticleIdList></Reference><Reference><Citation>Dols-Icardo O, Nebot I, Gorostidi A, Ortega-Cubero S, Hernandez I, Rojas-Garcia R et al (2015) Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain. Brain 138(Pt 12):e400</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv175</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone F, Nguyen HP, Van Mossevelde S, Moisse M, Sieben A, Santens P et al (2017) Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiol Aging 51:177.e9&#x2013;177e16</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE et al (2020) Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice. J Neurol Neurosurg Psychiatry 91(2):162&#x2013;171</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321790</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Glynn SM, Gibbs JR, Nalls MA, Sabatelli M, Restagno G, Drory VE, Chi&#xf2; A, Rogaeva E, Traynor BJ (2014) Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain 137(Pt 12):e311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>